Plasma matrix metalloproteinase-9 levels, MMP-9 gene haplotypes, and cardiovascular risk in obese subjects (2016)
- Authors:
- Autor USP: SANTOS, JOSE EDUARDO TANUS DOS - FMRP
- Unidade: FMRP
- DOI: 10.1007/s11033-016-3993-z
- Subjects: BIOMARCADORES; DOENÇAS CARDIOVASCULARES; POLIMORFISMO; OBESIDADE; FATORES DE RISCO
- Keywords: HAPLOTYPES; MATRIX METALLOPROTEINASE (MMP)- 9; METABOLIC RISK FACTORS; OBESITY; POLYMORPHISMS; TISSUE INHIBITOR OF MATRIX METALLOPROTEINASE (TIMP)-1
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título: Molecular Biology Reports
- ISSN: 0301-4851
- Volume/Número/Paginação/Ano: v. 43, n. 6, p. 463-471, 2016
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
LUIZON, Marcelo Rizzatti et al. Plasma matrix metalloproteinase-9 levels, MMP-9 gene haplotypes, and cardiovascular risk in obese subjects. Molecular Biology Reports, v. 43, n. 6, p. 463-471, 2016Tradução . . Disponível em: https://doi.org/10.1007/s11033-016-3993-z. Acesso em: 24 jan. 2026. -
APA
Luizon, M. R., Belo, V. A., Fernandes, K. S., Andrade, V. L., Tanus-Santos, J. E., & Sandrim, V. C. (2016). Plasma matrix metalloproteinase-9 levels, MMP-9 gene haplotypes, and cardiovascular risk in obese subjects. Molecular Biology Reports, 43( 6), 463-471. doi:10.1007/s11033-016-3993-z -
NLM
Luizon MR, Belo VA, Fernandes KS, Andrade VL, Tanus-Santos JE, Sandrim VC. Plasma matrix metalloproteinase-9 levels, MMP-9 gene haplotypes, and cardiovascular risk in obese subjects [Internet]. Molecular Biology Reports. 2016 ; 43( 6): 463-471.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1007/s11033-016-3993-z -
Vancouver
Luizon MR, Belo VA, Fernandes KS, Andrade VL, Tanus-Santos JE, Sandrim VC. Plasma matrix metalloproteinase-9 levels, MMP-9 gene haplotypes, and cardiovascular risk in obese subjects [Internet]. Molecular Biology Reports. 2016 ; 43( 6): 463-471.[citado 2026 jan. 24 ] Available from: https://doi.org/10.1007/s11033-016-3993-z - Blood transfusions increase circulating plasma free hemoglobin levels and plasma nitric oxide consumption: a prospective observational pilot study
- Comparative assessment of matrix metalloproteinase(MMP)-2 and MMP-9, and their inhibitors, tissue inhibitors of metalloproteinase (TIMP)-1 and TIMP-2 in preeclampsia and gestational hypertension
- Differences in both matrix metalloproteinase 9 concentration and zymographic profile between plasma and serum with clot activators are due to the presence of amorphous silica or silicate salts in blood collection devices
- Aminoguanidine produces beneficial haemodynamic effects in a canine model of acute pulmonary thromboembolism
- Sildenafil improves the beneficial hemodynamic effects exerted by atorvastatin during acute pulmonary thromboembolism
- Vascular xanthine oxidoreductase contributes to the antihypertensive effects of sodium nitrite in L-NAME hypertension
- Pharmacokinetics and QT interval pharmacodynamics of oral haloperidol in poor and extensive metabolizers of CYP2D6
- Increase in gastric pH reduces hypotensive effect of oral sodium nitrite in rats
- Nitrate decreases xanthine oxidoreductase-mediated nitrite reductase activity and attenuates vascular and blood pressure responses to nitrite
- eNOS gene polymorphirms may modify the effects produced by cardiovascular drugs on myocardial eNOS expression and activity [Carta]
Informações sobre o DOI: 10.1007/s11033-016-3993-z (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
